KORU Medical Systems, Inc. Common Stock (DE) (KRMD)

Price$3.93

Value ScoreF

Growth ScoreB

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-41.54%

Price vs S&P 500 (4W)-6.42%

VGM Score47.04

Market Capitalization$180.52M

All Metrics

P/CF (Annual)390.38x

Book Value / Share (Quarterly)$0.37

P/TBV (Annual)16.45x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)13.81%

Cash Flow / Share (Quarterly)$0.00

Price vs S&P 500 (YTD)-40.52%

Gross Margin (TTM)61.93%

Net Profit Margin (TTM)-5.27%

EPS (TTM)$-0.05

10-Day Avg Trading Volume0.09M

EPS Excl Extra (TTM)$-0.05

Revenue Growth (5Y)11.21%

EPS (Annual)$-0.06

ROI (Annual)-15.29%

Gross Margin (Annual)62.26%

Net Profit Margin (5Y Avg)-24.61%

Cash / Share (Quarterly)$0.19

Revenue Growth QoQ (YoY)22.10%

ROA (Last FY)-9.35%

Revenue Growth TTM (YoY)23.30%

EBITD / Share (TTM)$-0.04

ROE (5Y Avg)-31.84%

Operating Margin (TTM)-5.99%

Cash Flow / Share (Annual)$-0.01

P/B Ratio10.67x

P/B Ratio (Quarterly)12.12x

Net Income / Employee (Annual)$-36,100

EV / Revenue (TTM)3.97x

Net Interest Coverage (TTM)-317.00x

ROA (TTM)-8.33%

EV / EBITDA (TTM)1228.01x

EPS Incl Extra (Annual)$-0.06

Current Ratio (Annual)2.44x

Quick Ratio (Quarterly)1.70x

3-Month Avg Trading Volume0.17M

52-Week Price Return34.59%

Revenue / Employee (TTM)$592,600

Tangible BV / Share (Quarterly)$0.35

P/S Ratio (Annual)4.39x

Asset Turnover (Annual)1.46x

52-Week High$6.61

Operating Margin (5Y Avg)-26.19%

EPS Excl Extra (Annual)$-0.06

CapEx CAGR (5Y)-2.03%

Tangible BV CAGR (5Y)-14.26%

26-Week Price Return-33.61%

Quick Ratio (Annual)1.88x

13-Week Price Return-15.30%

Total Debt / Equity (Annual)0.01x

Current Ratio (Quarterly)2.33x

Enterprise Value$171.92M

Revenue / Share Growth (5Y)9.08%

Asset Turnover (TTM)1.58x

Book Value / Share Growth (5Y)-15.15%

Revenue / Employee (Annual)$563,400

Inventory Turnover (Annual)4.79x

Pretax Margin (Annual)-6.36%

Cash / Share (Annual)$0.19

3-Month Return Std Dev46.27%

Gross Margin (5Y Avg)59.59%

Net Income / Employee (TTM)$-31,200

ROE (Last FY)-15.47%

Net Interest Coverage (Annual)-189.80x

EPS Basic Excl Extra (Annual)$-0.06

P/FCF (TTM)265.71x

Receivables Turnover (TTM)7.25x

EV / Free Cash Flow (TTM)1494.97x

Total Debt / Equity (Quarterly)0.01x

EPS Incl Extra (TTM)$-0.05

Receivables Turnover (Annual)6.89x

ROI (TTM)-13.37%

P/S Ratio (TTM)4.17x

Pretax Margin (5Y Avg)-24.80%

Revenue / Share (Annual)$0.89

Tangible BV / Share (Annual)$0.35

Price vs S&P 500 (52W)10.22%

Year-to-Date Return-32.36%

5-Day Price Return-3.44%

EPS Normalized (Annual)$-0.06

ROA (5Y Avg)-22.28%

Net Profit Margin (Annual)-6.41%

Month-to-Date Return-3.20%

Cash Flow / Share (TTM)$-0.17

EBITD / Share (Annual)$-0.05

Operating Margin (Annual)-7.23%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)252.63x

ROI (5Y Avg)-30.89%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.05

P/TBV (Quarterly)12.66x

P/B Ratio (Annual)15.79x

Inventory Turnover (TTM)4.25x

Pretax Margin (TTM)-5.22%

Book Value / Share (Annual)$0.37

Price vs S&P 500 (13W)-23.56%

Beta0.45x

P/FCF (Annual)180.52x

Revenue / Share (TTM)$0.93

ROE (TTM)-13.61%

52-Week Low$2.77

vGradeF

gGradeB

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.02est. -0.02

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.00

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
KRMDKORU Medical Systems, Inc. Common Stock (DE)	F	B	C	$3.93
SYKStryker Corporation	C	C	C	$305.66
MMM3M Company	C	F	C	$153.76
BSXBoston Scientific Corp.	C	B	D	$48.55
MDLNMedline Inc. Class A common stock	C	D	D	$33.61
BDXBecton, Dickinson and Co.	B	C	C	$151.16
RMDResMed Inc.	C	B	C	$196.04
DXCMDexCom, Inc.	C	B	C	$72.86
WSTWest Pharmaceutical Services, Inc.	D	C	B	$314.50
SOLVSolventum Corporation	C	D	B	$81.01
PENPenumbra, Inc.	F	C	B	$320.53

About

KORU Medical Systems develops and manufactures subcutaneous infusion devices designed to deliver immunoglobulin therapies for patients with primary immunodeficiencies and chronic inflammatory demyelinating polyneuropathy. The company's flagship FREEDOM Infusion System product line includes the FREEDOM60 and FreedomEdge syringe drivers along with complementary delivery components. KORU serves the home and clinical infusion therapy market for chronic immunological disorders.